Harmonic Discovery utilizes machine learning for precision pharmacology, developing next-generation medicines by addressing disease complexity through multi-targeted drug discovery.
Employees
8
Founded
2021
Revenue
$0-5M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
Engineering precision pharmacology, generative chemistry platform, multi-targeted drug discovery, integration of bioactivity data types, rational drug design.
How much Harmonic Discovery raised
Seed - $8 million
September 8, 2022
Lead Investor: Innovation Endeavors, Fifty Years, Y Combinator, and other select investors.